OTC DEFICIENCY

Clinical trials for OTC DEFICIENCY explained in plain language.

Never miss a new study

Get alerted when new OTC DEFICIENCY trials appear

Sign up with your email to follow new studies for OTC DEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 2 Terminated 1

Experimental OTC drug trial halted early

Disease control Terminated

This study tested a new medicine called ARCT-810 in people aged 12 to 65 with OTC deficiency, a rare genetic disorder that causes dangerous ammonia buildup. The goal was to see if the drug is safe and how the body processes it. The trial was stopped early, so results are limited.

Matched conditions: OTC DEFICIENCY

Phase: PHASE2 • Sponsor: Arcturus Therapeutics, Inc. • Aim: Disease control

Last updated May 04, 2026 16:24 UTC

OTC DEFICIENCY

Get alerted when new OTC DEFICIENCY trials appear

Experimental OTC drug trial halted early